logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: Tumor
Load new posts () and activity
Like Reblog Comment
text 2021-08-18 08:05
Brain Tumor Diagnosis And Therapeutics Market Poised to Reach USD 773.1 million By 2025 | Major Players : Merck & Co & Mankind Pharma

Global brain tumor diagnosis and therapeutics market size are anticipated to reach USD 773.1 million by 2025. A brain tumor could be defined as an uncontrolled and abnormal proliferation of cells in the brain. The factors that propel the growth of the brain tumor diagnosis and therapeutics industry include increasing requirement of treatment for symptoms related to brain metastasis, advancement in R&D technologies, increased occurrence of cancer that spread to the brain, discoveries in novel drug transfer to brain tumor cells, increasing the competence of diagnosis, increasing awareness among population.

 

On the other hand, there are factors that could hamper the growth of the market including side effects associated with the chemotherapy and high cost of treatment. Brain tumor diagnosis & therapeutics market are anticipated to expand at a significant CAGR of 8.1% in the upcoming period as the scope, product types, and its applications are increasing across the globe.

 

Get Exclusive Free Sample Copy Of This Report @ https://bit.ly/3spCMq1

 

 

Brain tumor diagnosis and therapeutics industry could be explored by product type, diagnostic type, treatment type, end user, and geography. The industry could be explored by product type as Secondary Brain Tumor and Primary Brain Tumor (Gliomas, Meningioma, Pituitary Tumors, Astrocytoma’s and Others). The “Secondary Brain Tumor” segment led the brain tumor diagnosis and therapeutics market in 2017 and is anticipated to maintain its dominance by 2025. The key factors that may be attributed to the growth of market includes an increase in brain tumor incidences and CNS-related cancers in regions.  Based on diagnostic type, the brain tumor diagnosis and therapeutics industry could span EEG, MRI, Molecular Testing, CT Scan, PET-CT Scan, and Others. The “CT Scan” segment led the brain tumor diagnosis & therapeutics market in 2016 and is anticipated to maintain its dominance by 2025. The market could be explored based on treatment type as Immunotherapy, Surgery, Targeted Therapy, Radiation Therapy, and Chemotherapy. The “Chemotherapy” segment led the brain tumor diagnosis & therapeutics industry in 2017 and is anticipated to maintain its dominance by 2025. The key factor that may be attributed to the growth of the market include the presence of a huge research pipeline by the industry players. The market could be explored by the end user as Individual Pharmacies, Hospital Pharmacies, and Ambulatory Surgical Centers.

 

North America accounted for the major market share of the brain tumor diagnosis and therapeutics in 2016 and will continue to lead in the forecast period. The factors that could be attributed to the growth include established healthcare infrastructure coupled with increasing consciousness regarding progressive technologies amongst the population in this region. Furthermore, increasing consumer disposable income supported by healthcare reimbursement and insurance policies in the U.S. is anticipated to spur development. North America is followed by the European region owing to growing government initiatives and increasing brain tumor cases.

 

Some of the key players that fuel the growth of the brain tumor diagnosis and therapeutics market comprise Bristol Myers Squibb, Genentech U.S.A, AstraZeneca plc, Hoffmann- La Roche, Pfizer, Inc., Antisense Pharma, Novartis AG, Dr. Reddy's Laboratories Ltd, Macleods Pharmaceutical Limited, Merck & Co, and Mankind Pharma. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

 

View Full Report with TOC @ https://bit.ly/3D79Hoe

 

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

 

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com

Source: bit.ly/3spCMq1
Like Reblog Comment
text 2020-07-01 11:52
Circulating Tumor Cells (CTC) Market - Main Region Market Analysis

Circulating Tumor Cells (CTC) Market Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

 

The report firstly introduced the Circulating Tumor Cells (CTC) basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

 

The report includes six parts, dealing with:

1.) Basic Information;
2.) Asia Circulating Tumor Cells (CTC) Market;
3.) North American Circulating Tumor Cells (CTC) Market;
4.) European Circulating Tumor Cells (CTC) Market;
5.) Market Entry and Investment Feasibility;
6.) Report Conclusion.

 

Request a Free Sample Copy of Circulating Tumor Cells (CTC) Market Report @  https://www.radiantinsights.com/research/global-circulating-tumor-cells-ctc-market-research-report-2019/request-sample

 

Table of Contents

 

Part I Circulating Tumor Cells (CTC) Industry Overview

 

Chapter One Circulating Tumor Cells (CTC) Industry Overview
1.1 Circulating Tumor Cells (CTC) Definition
1.2 Circulating Tumor Cells (CTC) Classification Analysis
1.2.1 Circulating Tumor Cells (CTC) Main Classification Analysis
1.2.2 Circulating Tumor Cells (CTC) Main Classification Share Analysis
1.3 Circulating Tumor Cells (CTC) Application Analysis
1.3.1 Circulating Tumor Cells (CTC) Main Application Analysis
1.3.2 Circulating Tumor Cells (CTC) Main Application Share Analysis
1.4 Circulating Tumor Cells (CTC) Industry Chain Structure Analysis
1.5 Circulating Tumor Cells (CTC) Industry Development Overview
1.5.1 Circulating Tumor Cells (CTC) Product History Development Overview
1.5.1 Circulating Tumor Cells (CTC) Product Market Development Overview
1.6 Circulating Tumor Cells (CTC) Global Market Comparison Analysis
1.6.1 Circulating Tumor Cells (CTC) Global Import Market Analysis
1.6.2 Circulating Tumor Cells (CTC) Global Export Market Analysis
1.6.3 Circulating Tumor Cells (CTC) Global Main Region Market Analysis
1.6.4 Circulating Tumor Cells (CTC) Global Market Comparison Analysis
1.6.5 Circulating Tumor Cells (CTC) Global Market Development Trend Analysis

 

Chapter Two Circulating Tumor Cells (CTC) Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Circulating Tumor Cells (CTC) Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

The report “Circulating Tumor Cells (CTC) Market” is available now at  https://www.radiantinsights.com/research/global-circulating-tumor-cells-ctc-market-research-report-2019

 

Part II Asia Circulating Tumor Cells (CTC) Industry (The Report Company Including the Below Listed But Not All)

 

Chapter Three Asia Circulating Tumor Cells (CTC) Market Analysis
3.1 Asia Circulating Tumor Cells (CTC) Product Development History
3.2 Asia Circulating Tumor Cells (CTC) Competitive Landscape Analysis
3.3 Asia Circulating Tumor Cells (CTC) Market Development Trend

 

Chapter Four 2014-2019 Asia Circulating Tumor Cells (CTC) Productions Supply Sales Demand Market Status and Forecast
4.1 2014-2019 Circulating Tumor Cells (CTC) Production Overview
4.2 2014-2019 Circulating Tumor Cells (CTC) Production Market Share Analysis
4.3 2014-2019 Circulating Tumor Cells (CTC) Demand Overview
4.4 2014-2019 Circulating Tumor Cells (CTC) Supply Demand and Shortage
4.5 2014-2019 Circulating Tumor Cells (CTC) Import Export Consumption
4.6 2014-2019 Circulating Tumor Cells (CTC) Cost Price Production Value Gross Margin

 

Like Reblog Comment
text 2020-06-08 11:38
Circulating Tumor Cells Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2020 to 2027

Circulating Tumor Cells Market is estimated to value over USD 13.78 billion by 2027 end and register a CAGR of 16% from the forecast period 2020-2027.

The report initiates from the outline of business surroundings and explains the commercial summary of chain structure. Moreover, it analyses forecast By Product Type, By Application, By Region and Circulating Tumor Cells Market forecast .

Additionally, this report illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This report provides valuable insights on the general market profit through a profit graph, an in depth SWOT analysis of the market trends alongside the regional proliferation of this business vertical.

Request a Free Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=5704&page=requestsample

                       

Market Segmentation:

This Market is divided By Product Type, By Application and By Region.

Regionally, the worldwide Circulating Tumor Cells Market is fragmented as North America, Europe, Asia Pacific and also the rest of the world.

 

Key Market Players:

Major market players enclosed within this market are

  • JANSSEN
  • QIAGEN(ADNAGEN)
  • Acousys Biodevices, Inc
  • ApoCell
  • Advanced Cell Diagnostics
  • Fluxion Biosciences
  • Biocept
  • Fluidigm
  • Epic Sciences
  • Clearbridge Biomedics

(Note: The list of the key players are going to be updated with the most recent market scenario and trends)

Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=5704&page=askfordiscount


FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points touching market growth


Competitive Landscape:

  • Tier 1 players- well-established companies in the market accounting a major market share  
  • Tier 2 players 
  • Rapidly growing players
  • New Entrants


Objectives of the Study:

  • To offer with an complete analysis on the Circulating Tumor Cells Market By Product Type, By Application and By Region
  • To cater comprehensive data on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To measure and forecast micro-markets and also the overall market
  • To predict the market size, in key regions — North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate the competitive landscape mapping - product launches, technological advancements, mergers and expansions

 

Browse Packaging and Labelling Research Reports & Consulting

  • Polyethylene Terephthalate (Pet) Packaging Market is predicted to value over US $ 3 billion by 2027, and register a CAGR of 5.9% during the forecast period 2020 to 2027. Polyethylene Terephthalate (PET), is a polyester that is shaped or expelled into plastic boxes or jugs for food and refreshments packaging, personal care items and many more.
  • Track and Trace Solutions Market is estimated to value over USD 4.5 billion by 2027 end and register a CAGR of over 14% during the forecast period 2020 to 2027. Product-wise, the market is bifurcated into software solutions and hardware solutions.

 

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

About FutureWise Research:

We specialize in high-growth niche market research, assuring flexibility, agility and customized solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

 

Company Name: FutureWise Research

Contact Person:  Vinay Thaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 347 709 4931

City:  Leeds

Country:  United Kingdom

Website: www.futurewiseresearch.com

More posts
Your Dashboard view:
Need help?